Cargando…
Nicotinamide mononucleotide attenuates glucocorticoid-induced osteogenic inhibition by regulating the SIRT1/PGC-1α signaling pathway
Long-term and high-dose glucocorticoid treatment is recognized as an important influencing factor for osteoporosis and osteonecrosis. Nicotinamide mononucleotide (NMN) is an intermediate of NAD(+) biosynthesis, and is widely used to replenish the levels of NAD(+). However, the potential role of NMN...
Autores principales: | Huang, Rui-Xiong, Tao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248519/ https://www.ncbi.nlm.nih.gov/pubmed/32377728 http://dx.doi.org/10.3892/mmr.2020.11116 |
Ejemplares similares
-
Nicotinamide mononucleotide attenuates HIF-1α activation and fibrosis in hypoxic adipose tissue via NAD(+)/SIRT1 axis
por: Wu, Keke, et al.
Publicado: (2023) -
Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
por: Wang, Sufan, et al.
Publicado: (2018) -
β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice
por: Li, Hui-ru, et al.
Publicado: (2023) -
Nicotinamide mononucleotide induces lipolysis by regulating ATGL expression via the SIRT1-AMPK axis in adipocytes
por: Imi, Yukiko, et al.
Publicado: (2023) -
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Ratajczak, Joanna, et al.
Publicado: (2016)